MOLLY WILLIAMS: Open Payments
NPI 1598536526 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $82 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: RINVOQ, SUFLAVE, TREMFYA, LINZESS, DUPIXENT, IBSRELA, XIFAXAN, ENTYVIO.
Industry payments across SC — which companies pay providers there.
